DOI:
10.1055/s-00000094
Zeitschrift für Gastroenterologie
LinksClose Window
References
Hsu CH et al.
Efficacy and tolerability of bevacizumab plus capecitabine as first-line therapy in patients with advanced hepatocellular carcinoma.
Br J Cancer 2010;
102 (06) 981-986
Search in:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.